Asia-Pacific dental membrane and bone graft substitute market is projected to register a CAGR of 10.4% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
Asia-Pacific Dental Membrane and Bone Graft Substitute Market, By Product Type (Bone Graft Substitute, Dental Membrane), Materials (Human Cells Source, Collagen, Hydroxyapatite (HA), Hydrogel, Tricalcium Phosphate (TCP), Polytetrafluoroethylene (PTFE), Others), Procedure Type (Socket Preservation, Sinus Lift/Sinus Augmentation, Ridge Augmentation, Periodontal Defect Regeneration, Implant Bone Regeneration, Others), End User (Dental Clinics, Hospitals, Ambulatory Surgical Center, Others), Country (Japan, China, Australia, South Korea, India, Malaysia, Singapore, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Asia-Pacific dental membrane and bone graft substitute market are:

• Growing geriatric population
• Growing medical tourism for dental procedures
Market Players:

The key market players for Asia-Pacific dental membrane and bone graft substitute market are listed below:

• Dentsply Sirona
• Zimmer Biomet
• Medtronic
• Institut Straumann AG
• Geistlich Pharma AG
• NovaBone Products, LLC
• Implantdirect (A Subsidiary of Envista)
• Nobel Biocare Services AG (A Subsidiary of Danaher)
• BioHorizons
• B&B Dental Implant Company